According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention

According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention

Pfizer Company Press Release.

Saved in:

Bibliographic Details
Main Author:	Company Pfizer
Format:	Article
Language:	English
Published:	Столичная издательская компания 2019-09-01
Series:	Рациональная фармакотерапия в кардиологии
Online Access:	https://www.rpcardio.online/jour/article/view/2015
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Coronary Artery Ectasia in Acute Coronary Syndrome: The Role of Non-vitamin K Antagonist Oral Anticoagulants in Management
by: Mahmoud Izraiq, et al.
Published: (2024-11-01)

CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: S. V. Nedogoda, et al.
Published: (2017-03-01)

Safety and effectiveness of Rivaroxaban, Dabigatran and Apixaban in patients with non-valvular atrial fibrillation for stroke prophylaxis
by: Ceyda Tanoğlu, et al.
Published: (2025-07-01)

Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist
by: S. I. Farag, et al.
Published: (2020-09-01)

COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2015-09-01)

When Prevention is Truly Better than Cure: Contrast-Associated Acute Kidney Injury in Percutaneous Coronary Intervention
by: Isaac Tea, et al.
Published: (2022-09-01)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021-05-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Clinical Outcomes of Non Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Non Valvular Atrial Fibrillation Patients: A Cohort Study in a Rural Tertiary Care Hospital, Gujarat, India
by: Sohilkhan Riyazkhan Pathan, et al.
Published: (2025-07-01)

Oral anticoagulants versus vitamin K antagonists in the treatment of non-valvular atrial fibrillation in patients with stage 4-5 chronic kidney disease
by: E. G. Skorodumova, et al.
Published: (2024-04-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

Assessment of Coronary Artery Disease in Non-Valvular Atrial Fibrillation: Is This Light at the End of the Tunnel?
by: Batta A, et al.
Published: (2024-11-01)

Percutaneous Coronary Intervention in Anomalous Right Coronary Artery: Ready to Implement in Clinical Routine?
by: Anselm W Stark, et al.
Published: (2022-10-01)

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes
by: Ryaan EL‐Andari, et al.
Published: (2025-06-01)

Prognostic factors for stent restenosis in patients with coronary artery disease undergoing percutaneous coronary intervention
by: M. А. Meshkova, et al.
Published: (2025-06-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)

Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
by: A. V. Svarovskaya, et al.
Published: (2020-07-01)

Augustus’ solar meridian functioning and the birth of the western leap year
by: V. Baiocchi, et al.
Published: (2025-05-01)

APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN
by: O. D. Ostroumova, et al.
Published: (2018-07-01)

The effect of coronary stent policies on the risk of percutaneous coronary intervention among acute coronary syndrome patients in Shanghai: Real-world evidence.
by: Zhenyi Shao, et al.
Published: (2024-01-01)

Short-term effects of PCSK-9 inhibitors on percutaneous coronary intervention in patients with acute coronary syndrome
by: Dong Hyun Gim, et al.
Published: (2025-05-01)

Syphilitic Coronary Artery Ostial Stenosis Resulting in Acute Myocardial Infarction Treated by Percutaneous Coronary Intervention
by: Marcelo A. Nakazone, et al.
Published: (2010-01-01)

Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01)

Robotic Percutaneous Coronary Intervention: The Good, the Bad, and What is to Come
by: Laura Young, et al.
Published: (2022-01-01)

Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
by: Despoina-Rafailia Benetou, et al.
Published: (2021-10-01)

Postmyocardial syndrome after myocardial infarction and percutaneous coronary intervention
by: A. A. Klimenko, et al.
Published: (2024-12-01)

Percutaneous Coronary Intervention in Pregnancy: Modeling of the Fetal Absorbed Dose
by: Kfier Kuba, et al.
Published: (2019-01-01)

Conventions in the XXth Century Drame (Augustus Strindberg and Eugene O'Neill)
by: Galina Baužytė
Published: (1972-12-01)

Emergency percutaneous coronary intervention of the left main in a young patient with acute coronary syndrome: stepping in the dark?
by: Dusan Ruzicic, et al.
Published: (2024-11-01)

Practice of percutaneous coronary interventions in non-ST-elevation acute coronary syndrome (based on the CONTRAST registry data)
by: S. Yu. Martsevich, et al.
Published: (2025-08-01)

CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
by: O. Iu. Mironova, et al.
Published: (2020-12-01)

The Role of Endothelin‐1, Kidney Function and Diabetes in Patients With Coronary Artery Disease Underwent Percutaneous Coronary Intervention
by: Zixiang Ye, et al.
Published: (2025-07-01)

Characteristics of patients with coronary artery disease and type 2 diabetes mellitus undergoing elective percutaneous coronary intervention
by: Anastasiya G. Neeshpapa, et al.
Published: (2025-01-01)

ASSOCIATION OF HIGH LIPOPROTEIN(a) LEVELS WITH CORONARY ARTERY PATENCY DURING THE FIRST YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS
by: M. V. Ezhov, et al.
Published: (2014-07-01)

Prevalence of CYP2C19 Gene Polymorphism in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
by: Maya Rosana Amalia, et al.
Published: (2021-12-01)

Outcomes of percutaneous coronary intervention in COVID-19-positive acute coronary syndrome patients: a retrospective study in Vietnam
by: Duy Cao Phuong Le, et al.
Published: (2025-07-01)

Prognostic Effect of pan-Immune-Inflammation Value Indices in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Yan Liu MM, et al.
Published: (2025-05-01)

Influence of multimorbidity on the risk of events in men with chronic coronary artery disease after myocardial infarction and percutaneous coronary intervention
by: D. V. Dedov, et al.
Published: (2023-12-01)

CASE OF CORONARY ARTERY SPASM WITH FATAL OUTCOME IN THE EARLY PERIOD AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY OF THE RIGHT CORONARY ARTERY WITH IMPLANTATION OF BARE METAL STENTS
by: Z. G. Tatarintseva, et al.
Published: (2021-03-01)